WASHINGTON -- Just about every policy lawmakers are considering for a deal to avert the so-called fiscal cliff would involve either raising individual...

WASHINGTON -- The Obama administration has alarmed global health experts by opposing a new international fund that would fight disease in the developi...

By Kimberly Leonard, iWatch NewsA federal judge's decision to block imports of a drug used in executions will leave states to rely more on a substit...

Ryan Grim contributed reporting WASHINGTON -- A month ago, Google lobbyist Katherine Oyama absorbed one of the more unusual congressional tongue-la...

So far in this election cycle, the only vaguely relevant recognition of the importance of leadership in biotechnology for the country's future was a polemical and uninformative exchange on vaccination policy.

WASHINGTON -- At a House Judiciary Committee hearing Wednesday, Democrats and Republicans joined together to voice support for legislation that would ...

This piece is a continuation of The Huffington Post's collaboration on trade issues with The Dylan Ratigan Show, called Trading Our Future. WASHING...

WASHINGTON -- After months of dead-end negotiations over raising the federal debt ceiling, President Barack Obama walked into the East Room of the Whi...

WASHINGTON -- Democrats have targeted pharmaceutical profits as a means of raising revenue as part of the debt ceiling deal, Rep. Chris Van Hollen (D-...

How does a policy earmark worth more than $214 million garner the votes of conservatives such as GOP Reps. Michele Bachmann (Minn.) and Ron Paul (Texa...

WASHINGTON — Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President ...

WASHINGTON — The head of the influential trade association for drug manufacturers announced Thursday night that he is leaving his job. The deve...

Sen. Bill Nelson, a Florida Democrat, said on Sunday that if leadership doesn't work with him on his amendment that would break the White House deal w...

The drug industry stands to gain in a health-care overhaul by getting tens of millions of newly insured customers, while insurance companies -- especi...

Facing last-minute liberal resistance in Congress, the drug industry is bracing for an increase in its share of the cost of the proposed health care o...

Republicans are preparing an alternative health-care bill to Democratic legislation, House Republican Leader John Boehner said, marking a shift in str...